Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × IT-101 × Clear all

NCT00753740 2020-06-12

Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

Phase 2 Withdrawn

Neoplasms, Ovarian Neoplasms

NCT01652079 2018-07-02

CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms